Is 2.5mg Mounjaro effective, or is it just a warm-up?

You've just started Mounjaro and the scales haven't moved much

This is one of the most common worries our prescribers hear. You ordered your first pen, started injecting once a week, and after a few weeks the number on the scales looks stubbornly familiar. Before concluding the medicine isn't working, it's worth understanding what the 2.5mg phase is actually for.

The starting dose exists primarily to let your digestive system settle. Tirzepatide slows gastric emptying and acts on two appetite-regulating receptors simultaneously — that dual action is powerful, and introducing it gradually reduces the risk of nausea, vomiting, and the GI discomfort that can make people stop treatment early. The first pen's job is adjustment, not transformation.

That framing isn't a marketing softener. The NHS medicines page on tirzepatide confirms that treatment begins at 2.5mg for tolerability, with dose increases managed by the prescriber over subsequent months. Expecting clinical-trial-level weight loss at 2.5mg is a little like expecting a car to reach motorway speed in first gear, the gear matters, it's just not where you stay.

Some people do notice meaningful early changes: appetite feels different, portions feel smaller, the urge to snack after dinner fades. Others notice almost nothing at this stage. Both experiences are normal, and neither predicts how you'll respond when the dose climbs.

Where the evidence on Mounjaro's effectiveness actually sits

The weight-loss results that make Mounjaro significant (around 20% average body-weight reduction over 72 weeks at the highest dose) come from the SURMOUNT-1 trial, published in the New England Journal of Medicine, and they were measured at maintenance doses, not at 2.5mg. NICE's appraisal of tirzepatide (TA1026) drew on that same evidence base when recommending the medicine for eligible adults.

This matters for interpreting your own experience at 2.5mg. The 2,539 participants in SURMOUNT-1 went through the same gradual titration you're going through. Their results were recorded after they'd reached and stayed at doses like 10mg or 15mg for most of the trial period. The 2.5mg phase is part of the same journey, not a different one.

If you're weighing up how 5mg compares to the starter dose once your titration begins, the page on whether 5mg Mounjaro is effective covers what changes at that next step. And if you're trying to understand the broader dose picture, our overview of which Mounjaro dose produces the most weight loss puts the full schedule into context.

Side effects at 2.5mg: lighter than you might expect, but worth knowing

The GI side effects associated with Mounjaro (nausea, loose stools, constipation, indigestion, burping) are most common in the first few days after a dose increase. At 2.5mg, many people find these are mild or barely noticeable precisely because the dose is low. That's a feature, not a coincidence.

If side effects do appear, they typically peak in the first week and settle as your body adjusts. Eating smaller meals, staying well hydrated, and avoiding rich or fatty foods during the adjustment window all help. Your prescriber and the Patient Information Leaflet that comes with your pen are the right places to turn for personal guidance on managing any symptoms, not general advice on the internet.

One thing worth noting for anyone on oral contraceptives: MHRA guidance advises adding a barrier method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying may reduce pill absorption. If that applies to you, it's worth flagging when you speak to your prescriber.

For a broader look at how Mounjaro works and what to expect across the whole treatment course, the Mounjaro overview page covers the full picture. Details on the 2.5mg pen format specifically are on the Mounjaro 2.5mg page.

What happens after 2.5mg, and how a prescriber decides

After four weeks at 2.5mg, your prescriber reviews your progress before any dose increase. That review at nume happens before every repeat, a real clinician reads your update, not software. The typical pathway moves from 2.5mg to 5mg, then upward in 2.5mg steps every four weeks, based on how well you're tolerating the current dose and whether continued titration is appropriate for you.

The doses where most participants in clinical trials saw the largest weight reductions are 10mg and 15mg, the comparison of Mounjaro doses by effectiveness has more detail on those figures. But reaching those doses safely is the point of starting low. Skipping the titration schedule isn't an option; it's how serious side effects happen.

Mounjaro is available privately in the UK, and the cost of treatment is a fair question to ask before you commit. Our Mounjaro pricing page explains what the private market looks like and what a legitimate price should include. For anyone curious about how the NHS route to tirzepatide works (and the strict criteria involved) the weight-loss treatments overview covers both routes plainly.

If you're ready to find out whether Mounjaro is suitable for you, a prescriber can review your circumstances properly. Check your eligibility with a free consultation, there's no obligation, and you'll get a same-day clinical assessment from a GPhC-registered prescriber.